Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid (R)) in patients with advanced solid tumors Article

cited authors

  • Kalmadi, S.; Davis, M.; Dowlati, A.; O'Keefe, S.; Cline-Burkhardt, M.; Pelley, R. J.; Borden, E.; Dreicer, R.; Bukowski, R.; Mekhail, T.

authors

Publication Date

  • June 1, 2007

webpage

published in

category

keywords

  • Carboplatin
  • Docetaxel
  • Revlimid
  • lenalidomide
  • phase I study
  • solid tumor

start page

  • 211

end page

  • 216

volume

  • 25

issue

  • 3